Study title: A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Lebwohl, Mark MD; The mometasone furoate study group. International Journal of Dermatology. 38(8):604-606, August 1999.A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Lebwohl, Mark MD; The mometasone furoate study group. International Journal of Dermatology. 38(8):604-606, August 1999.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Skin and Connective Tissue Diseases | |||||
Brands: Please see report, Please see report, Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: MOMETAZONE | |||||
ATC code: D07A C13 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |